Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Corrigendum to 'Toll-like receptors Expression and involvement in Multiple Myeloma' [Leukemia Research 34 (2010)1545-1550].

Chiron D, Jego G, Pellat-Deuceunynck C.

Leuk Res. 2019 Jun;81:106. doi: 10.1016/j.leukres.2017.11.003. No abstract available.

PMID:
31109444
2.

Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy.

Gozzi GJ, Gonzalez D, Boudesco C, Dias AMM, Gotthard G, Uyanik B, Dondaine L, Marcion G, Hermetet F, Denis C, Hardy L, Suzanne P, Douhard R, Jego G, Dubrez L, Demidov ON, Neiers F, Briand L, Sopková-de Oliveira Santos J, Voisin-Chiret AS, Garrido C.

Cell Death Differ. 2019 May 8. doi: 10.1038/s41418-019-0343-4. [Epub ahead of print]

PMID:
31068676
3.

Serpin B1 defect and increased apoptosis of neutrophils in Cohen syndrome neutropenia.

Duplomb L, Rivière J, Jego G, Da Costa R, Hammann A, Racine J, Schmitt A, Droin N, Capron C, Gougerot-Pocidalo MA, Dubrez L, Aral B, Lafon A, Edery P, Ghoumid J, Blair E, El Chehadeh-Djebbar S, Carmignac V, Thevenon J, Guy J, Girodon F, Bastie JN, Delva L, Faivre L, Thauvin-Robinet C, Solary E.

J Mol Med (Berl). 2019 May;97(5):633-645. doi: 10.1007/s00109-019-01754-4. Epub 2019 Mar 7.

PMID:
30843084
4.

HSP110 sustains chronic NF-κB signaling in activated B-cell diffuse large B-cell lymphoma through MyD88 stabilization.

Boudesco C, Verhoeyen E, Martin L, Chassagne-Clement C, Salmi L, Mhaidly R, Pangault C, Fest T, Ramla S, Jardin F, Wolz OO, Weber ANR, Garrido C, Jego G.

Blood. 2018 Aug 2;132(5):510-520. doi: 10.1182/blood-2017-12-819706. Epub 2018 Jun 5.

PMID:
29871863
5.

Hsp70: A Cancer Target Inside and Outside the Cell.

Boudesco C, Cause S, Jego G, Garrido C.

Methods Mol Biol. 2018;1709:371-396. doi: 10.1007/978-1-4939-7477-1_27. Review.

PMID:
29177673
6.

Modulation of the inwardly rectifying potassium channel Kir4.1 by the pro-invasive miR-5096 in glioblastoma cells.

Thuringer D, Chanteloup G, Boucher J, Pernet N, Boudesco C, Jego G, Chatelier A, Bois P, Gobbo J, Cronier L, Solary E, Garrido C.

Oncotarget. 2017 Jun 6;8(23):37681-37693. doi: 10.18632/oncotarget.16949.

7.

Serum Gp96 is a chaperone of complement-C3 during graft-versus-host disease.

Seignez A, Joly AL, Chaumonnot K, Hazoumé A, Sanka M, Marcion G, Boudesco C, Hammann A, Seigneuric R, Jégo G, Ducoroy P, Delarue P, Senet P, Castilla-Llorente C, Solary E, Durey MA, Rubio MT, Hermine O, Kohli E, Garrido C.

JCI Insight. 2017 Mar 23;2(6):e90531. doi: 10.1172/jci.insight.90531.

8.

HSP110 promotes colorectal cancer growth through STAT3 activation.

Berthenet K, Bokhari A, Lagrange A, Marcion G, Boudesco C, Causse S, De Thonel A, Svrcek M, Goloudina AR, Dumont S, Hammann A, Biard DS, Demidov ON, Seigneuric R, Duval A, Collura A, Jego G, Garrido C.

Oncogene. 2017 Apr 20;36(16):2328-2336. doi: 10.1038/onc.2016.403. Epub 2016 Nov 7.

PMID:
27819670
9.

Transfer of functional microRNAs between glioblastoma and microvascular endothelial cells through gap junctions.

Thuringer D, Boucher J, Jego G, Pernet N, Cronier L, Hammann A, Solary E, Garrido C.

Oncotarget. 2016 Nov 8;7(45):73925-73934. doi: 10.18632/oncotarget.12136.

10.

Extracellular HSP110 skews macrophage polarization in colorectal cancer.

Berthenet K, Boudesco C, Collura A, Svrcek M, Richaud S, Hammann A, Causse S, Yousfi N, Wanherdrick K, Duplomb L, Duval A, Garrido C, Jego G.

Oncoimmunology. 2016 Apr 22;5(7):e1170264. doi: 10.1080/2162402X.2016.1170264. eCollection 2016 Jul.

11.

The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development.

Joly AL, Deepti A, Seignez A, Goloudina A, Hebrard S, Schmitt E, Richaud S, Fourmaux E, Hammann A, Collura A, Svrcek M, Jego G, Robinet E, Solary E, Demidov O, Kohli E, Garrido C.

Oncogene. 2016 Jun 2;35(22):2948. doi: 10.1038/onc.2016.63. No abstract available.

PMID:
27251741
12.

Gap junction-mediated transfer of miR-145-5p from microvascular endothelial cells to colon cancer cells inhibits angiogenesis.

Thuringer D, Jego G, Berthenet K, Hammann A, Solary E, Garrido C.

Oncotarget. 2016 May 10;7(19):28160-8. doi: 10.18632/oncotarget.8583.

13.

Biofilms of Lactobacillus plantarum and Lactobacillus fermentum: Effect on stress responses, antagonistic effects on pathogen growth and immunomodulatory properties.

Aoudia N, Rieu A, Briandet R, Deschamps J, Chluba J, Jego G, Garrido C, Guzzo J.

Food Microbiol. 2016 Feb;53(Pt A):51-9. doi: 10.1016/j.fm.2015.04.009. Epub 2015 Apr 29.

PMID:
26611169
14.

The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development.

Joly AL, Deepti A, Seignez A, Goloudina A, Hebrard S, Schmitt E, Richaud S, Fourmaux E, Hammann A, Collura A, Svrcek M, Jego G, Robinet E, Solary E, Demidov O, Kohli E, Garrido C.

Oncogene. 2016 Jun 2;35(22):2842-51. doi: 10.1038/onc.2015.242. Epub 2015 Sep 14. Erratum in: Oncogene. 2016 Jun 2;35(22):2948.

PMID:
26364610
15.

Insulin response dysregulation explains abnormal fat storage and increased risk of diabetes mellitus type 2 in Cohen Syndrome.

Limoge F, Faivre L, Gautier T, Petit JM, Gautier E, Masson D, Jego G, El Chehadeh-Djebbar S, Marle N, Carmignac V, Deckert V, Brindisi MC, Edery P, Ghoumid J, Blair E, Lagrost L, Thauvin-Robinet C, Duplomb L.

Hum Mol Genet. 2015 Dec 1;24(23):6603-13. doi: 10.1093/hmg/ddv366. Epub 2015 Sep 10.

PMID:
26358774
16.

Oncogenic extracellular HSP70 disrupts the gap-junctional coupling between capillary cells.

Thuringer D, Berthenet K, Cronier L, Jego G, Solary E, Garrido C.

Oncotarget. 2015 Apr 30;6(12):10267-83.

17.

Do not stress, just differentiate: role of stress proteins in hematopoiesis.

Boudesco C, Rattier T, Garrido C, Jego G.

Cell Death Dis. 2015 Jan 29;6:e1628. doi: 10.1038/cddis.2014.560. No abstract available.

18.

The biofilm mode of life boosts the anti-inflammatory properties of Lactobacillus.

Rieu A, Aoudia N, Jego G, Chluba J, Yousfi N, Briandet R, Deschamps J, Gasquet B, Monedero V, Garrido C, Guzzo J.

Cell Microbiol. 2014 Dec;16(12):1836-53. doi: 10.1111/cmi.12331. Epub 2014 Sep 9.

PMID:
25052472
19.

Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes.

Jego G, Lanneau D, De Thonel A, Berthenet K, Hazoumé A, Droin N, Hamman A, Girodon F, Bellaye PS, Wettstein G, Jacquel A, Duplomb L, Le Mouël A, Papanayotou C, Christians E, Bonniaud P, Lallemand-Mezger V, Solary E, Garrido C.

Leukemia. 2014 Aug;28(8):1676-86. doi: 10.1038/leu.2014.63. Epub 2014 Feb 7.

PMID:
24504023
20.

Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells.

de Thonel A, Hazoumé A, Kochin V, Isoniemi K, Jego G, Fourmaux E, Hammann A, Mjahed H, Filhol O, Micheau O, Rocchi P, Mezger V, Eriksson JE, Rangnekar VM, Garrido C.

Cell Death Dis. 2014 Jan 23;5:e1016. doi: 10.1038/cddis.2013.532.

21.

Cohen syndrome is associated with major glycosylation defects.

Duplomb L, Duvet S, Picot D, Jego G, El Chehadeh-Djebbar S, Marle N, Gigot N, Aral B, Carmignac V, Thevenon J, Lopez E, Rivière JB, Klein A, Philippe C, Droin N, Blair E, Girodon F, Donadieu J, Bellanné-Chantelot C, Delva L, Michalski JC, Solary E, Faivre L, Foulquier F, Thauvin-Robinet C.

Hum Mol Genet. 2014 May 1;23(9):2391-9. doi: 10.1093/hmg/ddt630. Epub 2013 Dec 13.

PMID:
24334764
22.

Extracellular HSP27 mediates angiogenesis through Toll-like receptor 3.

Thuringer D, Jego G, Wettstein G, Terrier O, Cronier L, Yousfi N, Hébrard S, Bouchot A, Hazoumé A, Joly AL, Gleave M, Rosa-Calatrava M, Solary E, Garrido C.

FASEB J. 2013 Oct;27(10):4169-83. doi: 10.1096/fj.12-226977. Epub 2013 Jun 26.

PMID:
23804239
23.

Modulation of normal and malignant plasma cells function by toll-like receptors.

Jego G, Chiron D, Berthenet K, Pellat-Deceunynck C.

Front Biosci (Elite Ed). 2012 Jan 1;4:2289-301. Review.

PMID:
22202037
24.

Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis.

Dorard C, de Thonel A, Collura A, Marisa L, Svrcek M, Lagrange A, Jego G, Wanherdrick K, Joly AL, Buhard O, Gobbo J, Penard-Lacronique V, Zouali H, Tubacher E, Kirzin S, Selves J, Milano G, Etienne-Grimaldi MC, Bengrine-Lefèvre L, Louvet C, Tournigand C, Lefèvre JH, Parc Y, Tiret E, Fléjou JF, Gaub MP, Garrido C, Duval A.

Nat Med. 2011 Sep 25;17(10):1283-9. doi: 10.1038/nm.2457.

PMID:
21946539
25.

Hsp70: anti-apoptotic and tumorigenic protein.

Rérole AL, Jego G, Garrido C.

Methods Mol Biol. 2011;787:205-30. doi: 10.1007/978-1-61779-295-3_16.

PMID:
21898238
26.

Fine-tuning nucleophosmin in macrophage differentiation and activation.

Guery L, Benikhlef N, Gautier T, Paul C, Jego G, Dufour E, Jacquel A, Cally R, Manoury B, Vanden Berghe T, Vandenabeele P, Droin N, Solary E.

Blood. 2011 Oct 27;118(17):4694-704. doi: 10.1182/blood-2011-03-341255. Epub 2011 Aug 29.

27.

TLR9 ligand induces the generation of CD20+ plasmablasts and plasma cells from CD27+ memory B-cells.

Geffroy-Luseau A, Chiron D, Descamps G, Jégo G, Amiot M, Pellat-Deceunynck C.

Front Immunol. 2011 Dec 30;2:83. doi: 10.3389/fimmu.2011.00083. eCollection 2011.

28.

Targeting heat shock proteins in cancer.

Jego G, Hazoumé A, Seigneuric R, Garrido C.

Cancer Lett. 2013 May 28;332(2):275-85. doi: 10.1016/j.canlet.2010.10.014. Epub 2010 Nov 13. Review.

PMID:
21078542
29.

Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: role in osteoclastogenesis and bone resorption.

Baud'huin M, Ruiz-Velasco C, Jego G, Charrier C, Gasiunas N, Gallagher J, Maillasson M, Naggi A, Padrines M, Redini F, Duplomb L, Heymann D.

Eur J Cell Biol. 2011 Jan;90(1):49-57. doi: 10.1016/j.ejcb.2010.08.001. Epub 2010 Oct 20.

30.

Toll-like receptors: expression and involvement in multiple myeloma.

Chiron D, Jego G, Pellat-Deuceunynck C.

Leuk Res. 2010 Dec;34(12):1545-50. doi: 10.1016/j.leukres.2010.06.002. Epub 2010 Jul 1. Review. Erratum in: Leuk Res. 2019 Jun;81:106.

PMID:
20594595
31.

Toll-like receptors--sentries in the B-cell response.

Bekeredjian-Ding I, Jego G.

Immunology. 2009 Nov;128(3):311-23. doi: 10.1111/j.1365-2567.2009.03173.x. Review.

32.

Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.

Chiron D, Pellat-Deceunynck C, Maillasson M, Bataille R, Jego G.

J Immunol. 2009 Oct 1;183(7):4371-7. doi: 10.4049/jimmunol.0901436. Epub 2009 Sep 4.

33.

TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.

Chiron D, Pellat-Deceunynck C, Amiot M, Bataille R, Jego G.

J Immunol. 2009 Apr 1;182(7):4471-8. doi: 10.4049/jimmunol.0803113.

34.

Toll-like receptors: lessons to learn from normal and malignant human B cells.

Chiron D, Bekeredjian-Ding I, Pellat-Deceunynck C, Bataille R, Jego G.

Blood. 2008 Sep 15;112(6):2205-13. doi: 10.1182/blood-2008-02-140673. Epub 2008 Jun 30. Review.

35.

Osteoclasts support the survival of human plasma cells in vitro.

Geffroy-Luseau A, Jégo G, Bataille R, Campion L, Pellat-Deceunynck C.

Int Immunol. 2008 Jun;20(6):775-82. doi: 10.1093/intimm/dxn035. Epub 2008 Apr 8.

PMID:
18397910
36.

Evaluation of the impact of various agricultural practices on nitrate leaching under the root zone of potato and sugar beet using the STICS soil-crop model.

Jégo G, Martínez M, Antigüedad I, Launay M, Sanchez-Pérez JM, Justes E.

Sci Total Environ. 2008 May 15;394(2-3):207-21. doi: 10.1016/j.scitotenv.2008.01.021. Epub 2008 Mar 6.

PMID:
18328537
37.

Reactive plasmacytoses can mimick plasma cell leukemia: therapeutical implications.

Touzeau C, Pellat-Deceunynck C, Gastinne T, Accard F, Jego G, Avet-Loiseau H, Robillard N, Harousseau JL, Bataille R, Moreau P.

Leuk Lymphoma. 2007 Jan;48(1):207-8. No abstract available.

PMID:
17325872
38.

The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.

Bataille R, Jégo G, Robillard N, Barillé-Nion S, Harousseau JL, Moreau P, Amiot M, Pellat-Deceunynck C.

Haematologica. 2006 Sep;91(9):1234-40. Review.

39.

Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors.

Jego G, Bataille R, Geffroy-Luseau A, Descamps G, Pellat-Deceunynck C.

Leukemia. 2006 Jun;20(6):1130-7.

PMID:
16628189
40.

Lack of CD27 in myeloma delineates different presentation and outcome.

Moreau P, Robillard N, Jégo G, Pellat C, Le Gouill S, Thoumi S, Avet-Loiseau H, Harousseau JL, Bataille R.

Br J Haematol. 2006 Jan;132(2):168-70.

PMID:
16398651
41.

Immunotherapy via dendritic cells.

Palucka AK, Laupeze B, Aspord C, Saito H, Jego G, Fay J, Paczesny S, Pascual V, Banchereau J.

Adv Exp Med Biol. 2005;560:105-14. Review.

PMID:
15932026
42.

Rapid and precise method to locate microdialysis probe implantation in the rodent brain.

Bert L, Favale D, Jego G, Greve P, Guilloux JP, Guiard BP, Gardier AM, Suaud-Chagny MF, Lestage P.

J Neurosci Methods. 2004 Dec 30;140(1-2):53-7.

PMID:
15589334
43.

Dendritic cells control B cell growth and differentiation.

Jego G, Pascual V, Palucka AK, Banchereau J.

Curr Dir Autoimmun. 2005;8:124-39. Review.

PMID:
15564719
44.

Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice.

David DJ, Froger N, Guiard B, Przybylski C, Jego G, Boni C, Hunt SP, De Felipe C, Hamon M, Jacquot C, Gardier AM, Lanfumey L.

Eur J Pharmacol. 2004 May 10;492(1):41-8.

PMID:
15145704
45.

Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.

David DJ, Bourin M, Jego G, Przybylski C, Jolliet P, Gardier AM.

Br J Pharmacol. 2003 Nov;140(6):1128-36. Epub 2003 Oct 6.

46.

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6.

Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J.

Immunity. 2003 Aug;19(2):225-34.

47.

Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.

Gardier AM, David DJ, Jego G, Przybylski C, Jacquot C, Durier S, Gruwez B, Douvier E, Beauverie P, Poisson N, Hen R, Bourin M.

J Neurochem. 2003 Jul;86(1):13-24.

48.

Reactive plasmacytoses, a model for studying the biology of human plasma cell progenitors and precursors.

Pellat-Deceunynck C, Jego G, Robillard N, Accard F, Amiot M, Bataille R.

Hematol J. 2000;1(6):362-6. Review. No abstract available.

PMID:
11920215
49.

Interleukin-6 is a growth factor for nonmalignant human plasmablasts.

Jego G, Bataille R, Pellat-Deceunynck C.

Blood. 2001 Mar 15;97(6):1817-22.

PMID:
11238125
50.

Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSF.

Jego G, Avet-Loiseau H, Robillard N, Moreau P, Amiot M, Harousseau J, Pellat-Deceunynck C, Bataille R.

Leuk Res. 2000 Jul;24(7):627-30.

PMID:
10867139

Supplemental Content

Support Center